Aspirin may chase away bowel cancer

Taking regular doses of aspirin cannot only lower your risk for heart attack, but also decrease your chances of bowel cancer, says a recent report.  A low dose of aspirin, 75mg, which is the same dose recommended to take against heart attack, can also greatly reduce your risk for bowel cancer.

The report examines data developed over 20 years and also reveals that using the drug for a time of at least five years provides defence for a prolonged extent.  The results are based on studies of more than 14,000 people.

It has been found that the aspirin prohibits effects of proteins associated with many types of cancer.  It is now being suggested that preventive aspirin treatment become part of the regimen of the Government’s screening programme on bowel cancer.

Other studies have suggested that aspirin could be beneficial to people seeking to avoid bowel, breast, and prostate cancer.  This study on bowel cancer is viewed as definitive.

Many people ingest aspirin everyday as a sort of elixir against heart attack and other possible health problems.  This now seems a reasonable measure.  There has been a push for a sort of blanket prescribing of aspirin as a preventative for all sorts of health ailments, but aspirin has its side effects too.

You can’t just willy-nilly take aspirin, say some experts, because of stomach bleeding and ulcer proclivities.  The risks associated with taking aspirin should be weighed by your doctor before you develop any sort of routine for taking the drug.